On Monday, December 11, from 8:00am-5:00pm, we will perform annual maintenance of our website. During this time, some website functionality will be unavailable. Once complete, anything related to the 2023 session will be moved to the Archives. Mahalo for your understanding!

2024 HOUSE AND SENATE SESSION JOB OPPORTUNITIES AVAILABLE NOW

2020 Archives
You are viewing archived information from 2020
SB2362     
Measure Title: RELATING TO GENETICALLY MODIFIED MATERIAL.
Report Title: Genetically Modified Material; Biotechnology Companies; Written Disclosure
Description: Requires a biotechnology company that sells a genetically modified animal, plant, or seed that the company knows or has reason to believe will be used to produce an agricultural commodity to provide written disclosure of possible risks from the use of such an organism. Specifies that written notice does not waive any liability a biotechnology company may have toward a purchaser.
Companion:
Package: None
Current Referral: AEN/CPH, JDC/WAM
Introducer(s): ENGLISH, IHARA, KANUHA, KEITH-AGARAN, K. RHOADS, RUDERMAN, Baker, Dela Cruz, Fevella, Shimabukuro
Act:

Sort by Date Status Text
1/23/2020SReferred to AEN/CPH, JDC/WAM.
1/21/2020SPassed First Reading.
1/17/2020SIntroduced.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB2362
All Versions of this Measure

Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.

Testimony
No testimony available at this time.

Hearing Notices
No hearings scheduled